HUMA insider buying

2 cluster buys

Humacyte, Inc. · Healthcare

When two or more insiders at Humacyte, Inc. buy HUMA on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in HUMA plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
2
Distinct insiders
10
Total bought
$995.5K
Market cap
$207.8M

Detected clusters

  • Apr 7 – Apr 14, 2025
    Detected Apr 14, 2025
    High conviction6 insiders
    Total bought
    $146.1K
    Market cap
    $207.8M
  • May 15 – Dec 4, 2024
    Detected Dec 4, 2024
    High conviction5 insiders
    Total bought
    $849.4K
    Market cap
    $207.8M

All notable open-market buys in HUMA

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Apr 14, 2025
Chief Commercial Officer
6,493$1.54$10.0KSEC ↗
Apr 10, 2025
CFO and Chief Corp. Deve. Off.
20,000$1.53$30.6KSEC ↗
Apr 10, 2025
Chief Medical Officer
7,500$1.55$11.6KSEC ↗
Apr 8, 2025
Director
50,000$1.32$66.0KSEC ↗
Apr 8, 2025
Director
6,000$1.29$7.7KSEC ↗
Apr 7, 2025
Director
16,000$1.26$20.2KSEC ↗
Dec 4, 2024
Director
4,600$4.39$20.2KSEC ↗
Nov 19, 2024
Director
1,797$4.44$8.0KSEC ↗
Nov 19, 2024
Director, President, CEO and Director
1,797$4.44$8.0KSEC ↗
Aug 29, 2024
Director, President, CEO and Director
1,222$6.55$8.0KSEC ↗
Aug 29, 2024
Director
1,222$6.55$8.0KSEC ↗
Aug 15, 2024
Director
3,100$6.29$19.5KSEC ↗
Jun 4, 2024
Director, President, CEO and Director
2,362$6.35$15.0KSEC ↗
Jun 4, 2024
Director
2,362$6.35$15.0KSEC ↗
Jun 3, 2024
Director, President, CEO and Director
2,050$7.37$15.1KSEC ↗
Jun 3, 2024
Director
2,050$7.37$15.1KSEC ↗
May 20, 2024
Director
3,990$6.29$25.1KSEC ↗
May 20, 2024
Director
4,015$6.21$24.9KSEC ↗
May 15, 2024
Director
50,000$6.78$339.0KSEC ↗
May 15, 2024
Director
50,000$6.57$328.5KSEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

HUMA insider buying — FAQ

Are insiders buying HUMA stock?
Yes — 10 distinct insiders have bought HUMA (Humacyte, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Apr 15, 2025.
How much HUMA stock have insiders bought?
Insiders have bought a combined $995.5K of HUMA across 20 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in HUMA?
A cluster buy is two or more distinct Humacyte, Inc. insiders — officers, directors, or 10% owners — each buying HUMA on the open market within a rolling window. HUMA has 2 detected cluster buys to date.
Where does this HUMA insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in HUMA

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy HUMA within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding HUMA.